Hypomethylating agents plus venetoclax versus intensive chemotherapy prior to transplant in high-risk acute myeloid leukemia

Key Points

• To compare the effectiveness of hypomethylating agents combined with venetoclax against conventional intensive chemotherapy in treating high-risk acute myeloid leukemia prior to transplant.
• Comparative analysis of treatment regimens
• Focus on high-risk acute myeloid leukemia
• Assessment of outcomes before transplant
• Evaluation of survival rates under each treatment
• Comparison of remission rates post-intervention
• Insights into treatment-related toxicity levels